ArticleCancer2023

Erratum to "Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.